Up to 5-6% of asthmatics experience symptoms and exacerbations despite conventional treatments and have a major impact on health care systems. There is a pressing need to understand the pathophysiology of chronic severe asthma. These patients demonstrate relative resistance to the therapeutic effects of corticosteroids (CS). There are only a small number of these patients at any one institution. At the Royal Brompton Hospital, approximately 70 severe asthmatics per year are referred to a protocol for investigation and management. This project will investigate the inflammatory and cellular responses in chronic severe asthma, determine the role of CS responsiveness (CR) of these responses, and elucidate the cellular and molecular mechanisms of impaired CR. The hypothesis is that inflammatory pathways in severe asthma are magnified by signalling pathways, particularly the mitogen-activated protein kinases (MAPK), which in turn diminishes CS actions. CS actions may be impaired at receptor binding level, nuclear translocation of the activated receptor and inhibition of histone acetylation; the underlying molecular mechanisms will be investigated. Results obtained from chronic severe asthma patients will be compared to those from mild-to-moderate asthma who are well-controlled on moderate doses of inhaled CS. Sputum and blood samples will be obtained and alveolar macrophages, epithelial cells and submucosal tissue retrieved by fiberoptic bronchoscopy. The effects of an exacerbation and of high-dose oral CS will be examined. Airway tissues and cells will be analysed regarding the type of inflammation, activation of signalling pathways, releasability of cytokines, CS receptor nuclear translocation, and expression and acetylation of histones, and the effect of CS examined. The molecular mechanisms underlying loss of CR will be examined. These studies should lead to more effective therapies for chronic severe asthma.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL069155-02
Application #
6538109
Study Section
Special Emphasis Panel (ZHL1-CSR-H (S1))
Program Officer
Noel, Patricia
Project Start
2001-09-30
Project End
2006-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
2
Fiscal Year
2002
Total Cost
$325,381
Indirect Cost
Name
University of London National Heart/Lung Ins
Department
Type
DUNS #
City
London
State
Country
United Kingdom
Zip Code
Wysocki, Kenneth; Park, Seo Young; Bleecker, Eugene et al. (2014) Characterization of factors associated with systemic corticosteroid use in severe asthma: data from the Severe Asthma Research Program. J Allergy Clin Immunol 133:915-8
Witt, Chad A; Sheshadri, Ajay; Carlstrom, Luke et al. (2014) Longitudinal changes in airway remodeling and air trapping in severe asthma. Acad Radiol 21:986-93
Wu, Wei; Bleecker, Eugene; Moore, Wendy et al. (2014) Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data. J Allergy Clin Immunol 133:1280-8
Rao, Chitra K; Moore, Charity G; Bleecker, Eugene et al. (2013) Characteristics of perimenstrual asthma and its relation to asthma severity and control: data from the Severe Asthma Research Program. Chest 143:984-992
Li, Xingnan; Hawkins, Gregory A; Ampleford, Elizabeth J et al. (2013) Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients. J Allergy Clin Immunol 132:313-20.e15
Jarjour, Nizar N; Erzurum, Serpil C; Bleecker, Eugene R et al. (2012) Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. Am J Respir Crit Care Med 185:356-62
Li, Xingnan; Ampleford, Elizabeth J; Howard, Timothy D et al. (2012) Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases. J Allergy Clin Immunol 130:861-8.e7
Li, Xingnan; Ampleford, Elizabeth J; Howard, Timothy D et al. (2012) The C11orf30-LRRC32 region is associated with total serum IgE levels in asthmatic patients. J Allergy Clin Immunol 129:575-8, 578.e1-9
Luyster, Faith S; Teodorescu, Mihaela; Bleecker, Eugene et al. (2012) Sleep quality and asthma control and quality of life in non-severe and severe asthma. Sleep Breath 16:1129-37
Hawkins, Gregory A; Robinson, Mac B; Hastie, Annette T et al. (2012) The IL6R variation Asp(358)Ala is a potential modifier of lung function in subjects with asthma. J Allergy Clin Immunol 130:510-5.e1

Showing the most recent 10 out of 31 publications